Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Papageorgiou E, McLean RJ, Gottlob I. Nystagmus in childhood. Pediatr Neonatol. 2014;55:341–51.
Dunn M. Clinical assessment of nystagmus. Optometry Today. 2016;56:80–85.
Armstrong RA. Oculo-visual dysfunction in Parkinson’s disease. J Parkinsons Dis. 2015;5:715–26.
Harris CM, Taylor DS, Vellodi A. Ocular motor abnormalities in Gaucher disease. Neuropediatrics. 1999;30:289–93.
Blundell J, Frisson S, Chakrapani A, Kearney S, Vijay S, MacDonald A, et al. Markers of cognitive function in individuals with metabolic disease: Morquio syndrome and tyrosinemia type III. Cogn Neuropsychol. 2018;35:120–47.
Blundell J, Frisson S, Chakrapani A, Gissen P, Hendriksz C, Vijay S, et al. Oculomotor abnormalities in children with Niemann-Pick type C. Mol Genet Metab. 2018;123:159–68.
Hutton SB, Ettinger U. The antisaccade task as a research tool in psychopathology: a critical review. Psychophysiology. 2006;43:302–13.
Benson PJ, Beedie SA, Shephard E, Giegling I, Rujescu D, St Clair D. Simple viewing tests can detect eye movement abnormalities that distinguish schizophrenia cases from controls with exceptional accuracy. Biol Psychiatry. 2012;72:716–24.
Blekher TM, Yee RD, Kirkwood SC, Hake AM, Stout JC, Weaver MR, et al. Oculomotor control in asymptomatic and recently diagnosed individuals with the genetic marker for Huntington’s disease. Vision Res. 2004;44:2729–36.
Crawford TJ, Higham S, Renvoize T, Patel J, Dale M, Suriya A, et al. Inhibitory control of saccadic eye movements and cognitive impairment in Alzheimer’s disease. Biol Psychiatry. 2005;57:1052–60.
Boxer AL, Garbutt S, Seeley WW, Jafari A, Heuer HW, Mirsky J, et al. Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer disease. Arch Neurol. 2012;69:509–17.
White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA. Ocular motor deficits in Parkinson’s disease. II. Control of the saccadic and smooth pursuit systems. Brain. 1983;106:571–87.
Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79:368–76.
Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, et al. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78:565–70.
Rodrigue AL, Schaeffer DJ, Pierce JE, Clementz BA, McDowell JE. Evaluating the specificity of cognitive control deficits in schizophrenia using antisaccades, functional magnetic resonance imaging, and healthy individuals with poor cognitive control. Front Psychiatry. 2018;9:107.
Wade NJ, Tatler BW. Origins and applications of eye movement research. In ID Gilchrist & S Everling, editors. The Oxford handbook of eye movements. Oxford: Oxford University Press; 2011.
Wurtz RH. Using perturbations to identify the brain circuits underlying active vision. Philos Trans R Soc B. 2015;370:20140205.
Liversedge SP, Gilchrist ID, Everling S. The Oxford handbook of eye movements. Oxford: Oxford University Press; 2011.
Antoniades C, Ettinger U, Gaymard B, Gilchrist ID, Kristjansson A, Kennard C, et al. An internationally standardised antisaccade protocol for clinical use. Vision Res. 2013;84:1–5.
Author contributions
All authors contributed to the drafting and/or revision of this article. The manuscript was coordinated by R.C., I.D.G. and C.W.
Funding
The work was supported by a grant from the UK Engineering and Physical Sciences Research Council (EP/M000885/1) to the Bristol Vision Institute, which supported R.C. and a 1-day workshop on this topic at the University of Bristol on 24 April 2018. C.W. is supported by an NIHR senior research fellowship (SRF208-015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Clark, R., Blundell, J., Dunn, M.J. et al. The potential and value of objective eye tracking in the ophthalmology clinic. Eye 33, 1200–1202 (2019). https://doi.org/10.1038/s41433-019-0417-z
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-019-0417-z
This article is cited by
-
Spatial-chromatic encoding cosmetic contact lenses for enhanced natural eye tracking
Nature Communications (2026)
-
Accurate eye tracking from dense 3D surface reconstructions using single-shot deflectometry
Nature Communications (2025)
-
Analysis of Fibroblast Growth Factor 14 (FGF14) structural variants reveals the genetic basis of the early onset nystagmus locus NYS4 and variable ataxia
European Journal of Human Genetics (2023)
-
Eye Tracking in Virtual Reality: a Broad Review of Applications and Challenges
Virtual Reality (2023)
-
Management of nystagmus in children: a review of the literature and current practice in UK specialist services
Eye (2020)